FDA Inspection 792168 — Abon Biopharm (Hangzhou) Co., Ltd.
The FDA completed an inspection of Abon Biopharm (Hangzhou) Co., Ltd. on July 10, 2012 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2012
- Fiscal Year
- 2012
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hangzhou (China)